AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Benegliz-M Tablet

Prescription Icon
Prescription Required

Marketer

Bhesaja Remedies Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Benegliz-M Tablet

Diabex Duo tablets are classified as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking Diabex Duo even if feeling well or experiencing controlled blood sugar; abrupt cessation, without medical consultation, can elevate blood glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, Diabex Duo complements a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Common side effects of Diabex Duo include hypoglycemia (low blood sugar), bowel irregularity, and nausea. Learn to identify hypoglycemia symptoms—sweating, dizziness, headache, trembling—and appropriate management. Maintain consistent mealtimes and carry a readily available fast-acting glucose source, like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste perception, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment; Diabex Duo may be unsuitable. Pregnant or lactating women must consult their physician prior to use. Regular blood glucose monitoring is essential; your doctor may order blood tests to track blood cell counts and liver function.

Uses of Benegliz-M Tablet

Non-insulin-dependent diabetes

Major Benefits of Benegliz-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Benegliz-M Tablet with food.

Common Side effects of Benegliz-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Benegliz-M Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Benegliz-M Tablet with a meal.

How Benegliz-M Tablet works:

Gliclazide and metformin are combined in Benegliz-M tablets to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Benegliz-M Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Benegliz-M tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Benegliz-M tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose levels are abnormally high or low. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Benegliz-M Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Benegliz-M Tablet use. Physician consultation is essential. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Benegliz-M Tablets. Dosage modification may be necessary; physician consultation is advised. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, Benegliz-M Tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Benegliz-M Tablet :

Should you forget a Benegliz-M Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Benegliz-M Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Benegliz-M Tablet

Benegliz-M tablets contain gliclazide and metformin, a dual-action medication for managing type 2 diabetes mellitus in adults. It helps regulate blood sugar when combined with a healthy diet and exercise regimen. Gliclazide enhances insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves cellular insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Benegliz-M Tablet administration is linked to frequent adverse reactions. These may manifest as hypoglycemia, taste disturbances, nausea, abdominal discomfort, diarrhea, cephalalgia, and upper respiratory infections. While uncommon, serious adverse events such as lactic acidosis are possible. Prolonged therapy may also result in vitamin B12 depletion.
Indeed, Benegliz-M Tablet usage may lead to hypoglycemia, characterized by low blood glucose. Manifestations of this condition include nausea, headache, irritability, increased hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Indeed, Benegliz-M Tablet use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this is an uncommon adverse reaction to metformin. To prevent it, the medication is contraindicated in individuals with pre-existing kidney impairment, the elderly, and heavy alcohol consumers. Lactic acidosis symptoms might present as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Benegliz-M Tablet use and seek immediate medical attention.
Prolonged Benegliz-M Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications, including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at least annually, has been proposed by some researchers.
Patients exhibiting hypersensitivity to any Benegliz-M Tablet constituent or inactive ingredient should not use this medication. Similarly, its use is contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, encompassing diabetic ketoacidosis.
Combining Benegliz-M Tablet and alcohol is unsafe. This combination can exacerbate hypoglycemia and raise the risk of lactic acidosis.
Benegliz-M tablets contain gliclazide and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This combination therapy enhances blood sugar control when coupled with a healthy diet and regular physical activity. Gliclazide's mechanism involves stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose production and increases insulin sensitivity. This formulation is unsuitable for managing type 1 diabetes.
Benegliz-M Tablet administration is linked to several common adverse reactions. These can manifest as hypoglycemia, taste disturbances, nausea, abdominal discomfort, diarrhea, cephalalgia, and upper respiratory infections. Less frequent, but potentially severe, adverse events include lactic acidosis. Prolonged therapy may result in vitamin B12 deficiency.
Indeed, Benegliz-M Tablets may induce hypoglycemia—a condition characterized by low blood glucose. Manifestations of this include nausea, headache, irritability, increased hunger, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential complication of Benegliz-M Tablet use. Also termed Metformin-associated lactic acidosis (MALA), this adverse reaction, though uncommon, is linked to metformin. To mitigate risk, its use is contraindicated in individuals with kidney impairment, the elderly, and those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Benegliz-M Tablet immediately and seek medical attention.
Prolonged Benegliz-M Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication inhibits the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications, including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some studies.
Patients with hypersensitivity to any ingredient or inactive component in Benegliz-M Tablets should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Benegliz-M Tablet and alcohol is unsafe. This combination can dangerously reduce blood sugar, potentially leading to hypoglycemia and a heightened risk of lactic acidosis.
Benegliz-M Tablet
74
MRP 90
17% off